ÂÜÀòÂÒÂ×

Daniela Gruber is an experienced professional who has held various leadership positions in the pharmaceutical industry. Currently serving as the Director Portfolio Optimization at AOP Orphan Pharmaceuticals GmbH. Daniela has a strong background in business unit management, particularly in the areas of neurology, metabolic disorders, psychiatry, gastroenterology, gynaecology, and endocrinology. With a solid educational background from WU and the University of Graz, Daniela has also worked in marketing, product management, and consulting roles at reputable companies like ImClone Systems, sanofi-aventis, GlaxoSmithKline, and more.